Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.

Saved in:
Bibliographic Details
Title: Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.
Authors: Ren R; Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Wang N; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Hefei, Anhui, China., Chen C; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Hefei, Anhui, China., Yang M; Cornerstone of Health Technology (Shaanxi) Co., Ltd., Xianyang, Shaanxi, China., Li B; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Yang Y; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Zhang H; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Yang B; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Wu Y; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China., Gao W; Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Hou Y; Department of Anesthesiology, Xi'an Chest Hospital and Northwest University Affiliated Chest Hospital, Xi'an, Shaanxi, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Apr 30; Vol. 17, pp. 1695352. Date of Electronic Publication: 2026 Apr 30 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42147326
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ren+R%22">Ren R</searchLink>; Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Wang+N%22">Wang N</searchLink>; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Hefei, Anhui, China.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Hefei, Anhui, China.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; Cornerstone of Health Technology (Shaanxi) Co., Ltd., Xianyang, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Li+B%22">Li B</searchLink>; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Yang+B%22">Yang B</searchLink>; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; Department of Cardiothoracic and Vascular Surgery and Critical Care Medicine, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Gao+W%22">Gao W</searchLink>; Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Hou+Y%22">Hou Y</searchLink>; Department of Anesthesiology, Xi'an Chest Hospital and Northwest University Affiliated Chest Hospital, Xi'an, Shaanxi, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 Apr 30; Vol. 17, pp. 1695352. <i>Date of Electronic Publication: </i>2026 Apr 30 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42147326
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2026.1695352
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1695352
    Titles:
      – TitleFull: Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ren R
      – PersonEntity:
          Name:
            NameFull: Wang N
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Yang M
      – PersonEntity:
          Name:
            NameFull: Li B
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Yang B
      – PersonEntity:
          Name:
            NameFull: Wu Y
      – PersonEntity:
          Name:
            NameFull: Gao W
      – PersonEntity:
          Name:
            NameFull: Hou Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 04
              Text: 2026 Apr 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1